|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01255 TATA HEALTH
Nominal 
1.550 0.000 (0.000%) Profitability Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| ROAA (%) | 11.798% | -43.075% | -18.033% | 4.560% | -35.922% |
| ROAE (%) | N/A | N/A | -191.066% | 29.212% | -367.247% |
| Return on Capital Employed (%) | N/A | N/A | N/A | 29.182% | -222.551% |
Margin Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Gross Profit Margin (%) | 80.426% | 69.535% | 72.642% | 78.796% | 65.073% |
| EBITDA Margin (%) | 28.136% | -39.166% | -10.337% | 11.094% | -33.083% |
| Pre-tax Profit Margin (%) | 14.015% | -52.461% | -17.066% | 1.727% | -42.966% |
| Net Profit Margin (%) | 13.377% | -52.697% | -15.560% | 5.565% | -37.757% |
Liquidity Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Current Ratio (X) | 0.501 X | 0.613 X | 0.749 X | 0.674 X | 0.746 X |
| Quick Ratio (X) | 0.434 X | 0.554 X | 0.676 X | 0.531 X | 0.615 X |
Leverage Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Total Liabilities / Total Assets(%) | 159.744% | 141.556% | 108.880% | 90.156% | 92.308% |
| Total Debt / Total Assets (%) | 28.388% | 26.563% | 29.880% | 28.987% | 29.787% |
| Net Debt / Total Assets (%) | 8.722% | 9.550% | 7.914% | 9.874% | 14.666% |
| Total Debt / Shareholders' Funds (%) | N/A | N/A | 3161.825% | 159.066% | 228.953% |
| Long Term Debt / Shareholders' Funds (%) | N/A | N/A | 806.392% | 26.924% | 59.526% |
| Net Debt / Shareholders' Funds (%) | N/A | N/A | 837.478% | 54.184% | 112.729% |
| Net Cash / (Debt) ($) | (7.948M) | (12.911M) | (14.413M) | (17.384M) | (25.939M) |
| Net Cash / (Debt) per share ($) | (0.033) | (0.053) | (0.059) | (0.072) | (0.107) |
| Total Debt / Capital Employed (%) | N/A | N/A | N/A | 185.070% | 192.960% |
| Interest Coverage Ratio (X) | -- | N/A | N/A | 2.001 X | N/A |
Efficiency Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Inventory Turnover (Day) | 189.563 Day | 111.305 Day | 110.892 Day | 242.573 Day | 215.356 Day |
| Receivables Turnover (Day) | 15.800 Day | 18.785 Day | 14.523 Day | 19.703 Day | 16.928 Day |
| Payables Turnover (Day) | 14.015 Day | 12.154 Day | 12.454 Day | 16.020 Day | 5.738 Day |
| Remarks: | Real time quote last updated: 02/04/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD 13,350 |
| %Change | -- |
| EPS / (LPS) | HKD 0.050 |
| NBV Per Share ($) | HKD -0.224 |